Clinical trials
Terminated Osteosarcoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
41 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 3 |
| 2008 | 4 |
| 2009 | 2 |
| 2010 | 3 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 5 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 3 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 41 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 3 |
| Balgrist University Hospital | 2 |
| City of Hope Medical Center | 2 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2 |
| State University of New York - Upstate Medical University | 2 |
| Y-mAbs Therapeutics | 2 |
| AeRang Kim | 1 |
| BTG International Inc. | 1 |
| Barbara Ann Karmanos Cancer Institute | 1 |
| Bayer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Osteosarcoma | 41 |
| Sarcoma | 16 |
| Neuroblastoma | 12 |
| Neuroectodermal Tumors, Primitive, Peripheral | 9 |
| Sarcoma, Ewing | 8 |
| Bone Neoplasms | 6 |
| Neoplasms | 6 |
| Rhabdomyosarcoma | 6 |
| Wilms Tumor | 5 |
| Carcinoma, Renal Cell | 4 |
Trials
Showing 76 to 41 of 41. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.